XML 28 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Business Segment Information (Tables)
6 Months Ended
Jun. 30, 2020
Business Segment Information  
Schedule of operating results by business segment

The following tables summarize, for the periods indicated, operating results by business segment (in thousands):

    

    

    

Corporate

    

 

Pharmacy

and

 

    

Healthcare

    

Management

    

Elimination

    

Consolidated

 

Three Months Ended June 30, 2019

Managed care and other revenue

$

546,113

$

62,648

$

(147)

$

608,614

PBM revenue

 

 

550,010

 

(4,335)

 

545,675

Cost of care

 

(408,911)

 

 

 

(408,911)

Cost of goods sold

 

 

(505,203)

 

4,122

 

(501,081)

Direct service costs and other

 

(98,314)

 

(78,776)

 

(18,817)

 

(195,907)

Stock compensation expense (1)

 

2,237

 

2,124

 

846

 

5,207

Segment Profit (Loss)

$

41,125

$

30,803

$

(18,331)

$

53,597

    

    

    

Corporate

    

Pharmacy

and

    

Healthcare

    

Management

    

Elimination

    

Consolidated

Three Months Ended June 30, 2020

Managed care and other revenue

$

481,021

$

67,867

$

(177)

$

548,711

PBM revenue

 

 

556,195

 

(4,831)

 

551,364

Cost of care

 

(321,831)

 

 

 

(321,831)

Cost of goods sold

 

 

(532,685)

 

4,618

 

(528,067)

Direct service costs and other

 

(100,450)

 

(80,082)

 

(19,224)

 

(199,756)

Stock compensation expense (1)

 

2,102

 

1,939

 

2,551

 

6,592

Segment Profit (Loss)

$

60,842

$

13,234

$

(17,063)

$

57,013

    

    

    

Corporate

    

 

Pharmacy

and

 

Healthcare

Management

Elimination

Consolidated

 

Six Months Ended June 30, 2019

Managed care and other revenue

$

1,052,935

$

122,543

$

(316)

$

1,175,162

PBM revenue

 

 

1,106,575

 

(8,442)

 

1,098,133

Cost of care

 

(778,008)

 

 

 

(778,008)

Cost of goods sold

 

 

(1,035,410)

 

8,015

 

(1,027,395)

Direct service costs and other (1)

 

(198,424)

 

(158,411)

 

(41,372)

 

(398,207)

Stock compensation expense (1)

 

3,780

 

3,796

 

7,031

 

14,607

Segment Profit (Loss)

$

80,283

$

39,093

$

(35,084)

$

84,292

    

    

    

Corporate

    

 

Pharmacy

and

 

Healthcare

Management

Elimination

Consolidated

 

Six Months Ended June 30, 2020

Managed care and other revenue

$

969,927

$

132,302

$

(350)

$

1,101,879

PBM revenue

 

 

1,129,973

 

(9,398)

 

1,120,575

Cost of care

 

(670,939)

 

 

 

(670,939)

Cost of goods sold

 

 

(1,070,259)

 

8,951

 

(1,061,308)

Direct service costs and other (1)

 

(206,386)

 

(161,948)

 

(35,663)

 

(403,997)

Stock compensation expense (1)

 

3,863

 

4,046

 

4,480

 

12,389

Segment Profit (Loss)

$

96,465

$

34,114

$

(31,980)

$

98,599

(1)Stock compensation expense, changes in the fair value of contingent consideration recorded in relation to acquisitions and impairment of intangible assets are included in direct service costs and other operating expenses; however, these amounts are excluded from the computation of Segment Profit.
Schedule of reconciliation of Segment Profit to income before income taxes

The following table reconciles income from continuing operations before income taxes to Segment Profit from continuing operations (in thousands):

Three Months Ended

Six Months Ended

June 30, 

June 30, 

2019

    

2020

    

2019

    

2020

Income from continuing operations before income taxes

$

12,950

$

10,780

$

1,550

$

15,472

Stock compensation expense

 

5,207

 

6,592

 

14,607

 

12,389

Depreciation and amortization

 

28,191

 

23,888

 

53,608

 

47,246

Interest expense

 

9,070

 

7,995

 

18,107

 

16,953

Interest and other income

 

(1,821)

 

(551)

 

(3,580)

 

(1,770)

Special charges

8,309

8,309

Segment Profit from continuing operations

$

53,597

$

57,013

$

84,292

$

98,599